I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy and safety of abiraterone acetate plus prednisone ..:
Puente, Javier
;
González-Del-Alba, Aranzazu
;
Sala-Gonzalez, Núria
...
http://hdl.handle.net/10668/14363. , 2019
Link:
http://hdl.handle.net/10668/14363
RT Journal T1
Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)
UL https://suche.suub.uni-bremen.de/peid=base-ftsspa:oai:www.repositoriosalud.es:10668_14363&Exemplar=1&LAN=DE A1 Puente, Javier A1 González-Del-Alba, Aranzazu A1 Sala-Gonzalez, Núria A1 Méndez-Vidal, María José A1 Pinto, Alvaro A1 Rodríguez, Ángel A1 Cuevas Sanz, José Miguel A1 Muñoz Del Toro, Jacobo Rodrigo A1 Useros Rodríguez, Eduardo A1 García García-Porrero, Ángela A1 Vázquez, Sergio YR 2019 K1 Abiraterone acetate K1 Cabazitaxel K1 Chemotherapy K1 Metastatic castration-resistant prostate cancer K1 Sequence K1 Adenocarcinoma K1 Age Factors K1 Aged K1 80 and over K1 Anemia K1 Antineoplastic Agents K1 Hormonal K1 Antineoplastic Combined Chemotherapy Protocols K1 Asthenia K1 Docetaxel K1 Humans K1 Kaplan-Meier Estimate K1 L-Lactate Dehydrogenase K1 Male K1 Middle Aged K1 Multivariate Analysis K1 Pain K1 Prednisone K1 Progression-Free Survival K1 Proportional Hazards Models K1 Prospective Studies K1 Prostatic Neoplasms K1 Castration-Resistant K1 Spain K1 Taxoids K1 Treatment Outcome JF http://hdl.handle.net/10668/14363 LK http://hdl.handle.net/10668/14363 DO http://hdl.handle.net/10668/14363 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)